ORIGINAL RESEARCH
Published on 05 Aug 2022
MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression

doi 10.3389/fonc.2022.856580
- 1,436 views
- 6 citations
15k
Total downloads
45k
Total views and downloads
ORIGINAL RESEARCH
Published on 05 Aug 2022
MINI REVIEW
Published on 04 Jul 2022
REVIEW
Published on 07 Jun 2022
ORIGINAL RESEARCH
Published on 25 May 2022
ORIGINAL RESEARCH
Published on 20 May 2022
MINI REVIEW
Published on 25 Apr 2022
ORIGINAL RESEARCH
Published on 05 Apr 2022
ORIGINAL RESEARCH
Published on 23 Mar 2022
ORIGINAL RESEARCH
Published on 07 Mar 2022
SYSTEMATIC REVIEW
Published on 22 Nov 2021
ORIGINAL RESEARCH
Published on 19 Nov 2021
ORIGINAL RESEARCH
Published on 05 Nov 2021